However, the increase in vasopressor-free days did not reach statistical significance in a multivariable model and the reduction in mortality was not evidenced when patients treated with Seraph-100 were compared to a control group of an external cohort [ 91 ].
← all excerpts
Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future.
1
—
—